15676-99-0Relevant articles and documents
Anderson,R.J. et al.
, p. 735 - 737 (1970)
3 - Methyl pentyl acetate and flavoring agent -3 - mercapto
-
Paragraph 0061-0063, (2021/04/16)
To provide a novel flavoring agent.SOLUTION: Provided are a flavor improvement method of a perfume of a perfume composition comprising: a step of providing a flavoring agent comprising 3-mercapto-3-methyl pentyl acetate represented by the following formula (1), a flavoring agent containing it as an active ingredient, and a consumer goods containing the flavoring agent or the perfume composition; and, furthermore a step of blending the flavoring agent made of 3-mercapto-3-methyl pentyl acetate represented by the following formula (1) to the perfume composition, and a method of improving the perfume of the consumer goods comprising blending the flavoring agent or the perfume composition to the consumer goods.SELECTED DRAWING: None
DIHYDROOROTATE DEHYDROGENASE INHIBITORS
-
Page/Page column 153-154, (2020/08/22)
Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Embodiments of such compounds are represented by Formula (I) as follows: 5 wherein R1, R2, R3, R4, R5a, R5b, X and Y, are defined herein.
Novel diphenylmethyl compounds having mycobacterium tuberculosis inhibitory activity
-
Paragraph 0485-0488, (2019/02/13)
The invention relates to novel diphenylmethyl derivatives having mycobacterium tuberculosis inhibitory activity and a preparation method thereof and particularly relates novel diphenylmethyl derivatives having activity for inhibiting replicative and non-replicating mycobacterium tuberculosis and a preparation method thereof. In particular, the invention relates to compounds shown in the formula (I) or all possible isomers, prodrugs, pharmaceutically acceptable salts, solvates or hydrates thereof, wherein the variables are as described in the specification. The invention also relates to the preparation method of the compounds and their pharmaceutical compositions and a use of the compounds in preparation of drugs for treating mycobacterium tuberculosis infection-caused diseases.